UMN Pharma Inc.(TSE:4585) dropped from S&P Global BMI Index

UMN Pharma Inc. is a Japan-based biotechnology company mainly engaged in the biopharmaceuticals development business. The Company is engaged in the development, manufacturing and sales of biopharmaceuticals based on the baculovirus expression vector system (BEVS) manufacturing platform. The Company's pipelines include seasonal influenza vaccine UMN-0502, pandemic influenza vaccine UMN-0501, pandemic influenza vaccine UMN-0901 and norovirus/rotavirus vaccine UMN-2003.